Minocycline is a drug which induces skin
hyperpigmentation. Its frequency reaches up to 50% of treated patients. The adverse effect diminishes the great therapeutic potential of
minocycline, including antibacterial, neuroprotective, anti-inflammatory and anti-
cancer actions. It is supposed that an elevated
melanin level and drug accumulation in
melanin-containing cells are related to skin
hyperpigmentation. This study aimed to evaluate molecular and biochemical mechanism of
minocycline-induced
hyperpigmentation in human normal melanocytes, as well as the contribution of UV radiation to this side effect. The experiments involved the evaluation of cyto- and phototoxic potential of the drug using cell imaging with light and confocal microscopes as well as biochemical and molecular analysis of melanogenesis. We showed that
minocycline induced
melanin synthesis in epidermal melanocytes. The action was intensified by UV irradiation, especially with the UVB spectrum.
Minocycline stimulated the expression of
microphthalmia-associated transcription factor (MITF) and
tyrosinase (TYR) gene. Higher levels of
melanin and increased activity of
tyrosinase were also observed in treated cells. Moreover,
minocycline triggered the supranuclear accumulation of
tyrosinase, similar to UV radiation. The decreased level of premelanosome
protein PMEL17 observed in all
minocycline-treated cultures suggests disorder of the formation, maturation or distribution of melanosomes. The study revealed that
minocycline itself was able to enhance
melanin synthesis. The action was intensified by irradiation, especially with the UVB spectrum. Demonstrated results confirmed the potential role of
melanin and UV radiation
minocycline-induced skin
hyperpigmentation.